· Published by Health Canada · Official notice
In order to help prevent medication errors with the use of botulinum toxin products currently available on the Canadian market, Health Canada will be requesting that all manufacturers of these products revise their product labels to reflect that each product has its own individual potency and as such, is not interchangeable with other botulinum products.
The labelling changes are due to a risk evaluation of the active ingredients (Clostridium botulinum toxin type A and type B) within these products. Botulinum toxins are produced by different manufacturing processes, are obtained by different techniques and are derived from different Clostridium strains. As a result of these differences, these products cannot be interchanged as these changes can cause unexpected side-effects.
| Proprietary Name | New Non-Proprietary Name |
|---|---|
| Botox / Botox Cosmetic | OnabotulinumtoxinA |
| Xeomin / Xeomin Cosmetic | IncobotulinumtoxinA |
| Dysport | AbobotulinumtoxinA |
| Myobloc | RimabotulinumtoxinB |
Botox is indicated for the treatment of severe muscle spasm in the neck, eye and foot, for chronic migraines, incontinence, and for excessive sweating. Botox Cosmetic is indicated for cosmetic purposes, to treat facial wrinkling.
Dysport is indicated for the temporary improvement in the appearance of moderate to severe wrinkles in adult patients less than 65 years of age.
Xeomin is indicated for severe muscle spasm in the neck, eye and arm. Xeomin Cosmetic is indicated for the temporary improvement of moderate to severe frown lines in adult patients.
Myobloc is indicated for the treatment of adult patients with severe muscle spasm in the neck.